We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Clavis Pharma Elects Robert J. Spiegel to its Board of Directors

News   May 30, 2011

 
Clavis Pharma Elects Robert J. Spiegel to its Board of Directors
 
 
Advertisement
 

RELATED ARTICLES

New Framework Designed To Enable Efficient Synthesis of Complex Molecules

News

A research team led by scientists at Scripps Research has developed a theoretical approach that could aid the synthesis of highly complex, compact molecules.

READ MORE

Experts Respond to Reported Death of COVID-19 Vaccine Trial Participant

News

News has emerged from Brazil that a participant of the Phase III clinical trial investigating the COVID-19 vaccine, ChAdOX1, has died.

READ MORE

Synthesizing Bacteria-Killing Molecules From Wasp Venom

News

A team of researchers has engineered powerful new antimicrobial molecules from toxic proteins originally found in wasp venom.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE